“The team at Scius provided us with excellent strategic advice around this important announcement with AstraZeneca. They were very responsive, working out of hours to ensure everything got done and in order to secure the best possible coverage. We were delighted by the extensive amount of coverage that has helped to put us on the map as a global leader in developing our self-amplifying RNA platform.”

 Dr Mike Watson, Executive Chairman of VaxEquity